These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 28010132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment.
    Blais L, Bourbeau J, Sheehy O, LeLorier J.
    Can Respir J; 2004; 11(1):27-32. PubMed ID: 15010729
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.
    Cascini S, Kirchmayer U, Belleudi V, Bauleo L, Pistelli R, Di Martino M, Formoso G, Davoli M, Agabiti N.
    COPD; 2017 Jun; 14(3):311-317. PubMed ID: 28406337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids and hospitalisation due to exacerbation of COPD.
    Bourbeau J, Ernst P, Cockcoft D, Suissa S.
    Eur Respir J; 2003 Aug; 22(2):286-9. PubMed ID: 12952262
    [Abstract] [Full Text] [Related]

  • 9. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 15; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 12. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
    Morros R, Vedia C, Giner-Soriano M, Casellas A, Amado E, Baena JM, en representación de los investigadores del proyecto PNEUMOCORT.
    Aten Primaria; 2019 Apr 15; 51(6):333-340. PubMed ID: 29661670
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S, Amin AV, Loke YK.
    Arch Intern Med; 2009 Feb 09; 169(3):219-29. PubMed ID: 19204211
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug 09; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
    Sin DD, Man SF.
    Eur Respir J; 2003 Feb 09; 21(2):260-6. PubMed ID: 12608439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.